AAPL332.77+0.50 (+0.15%) ▲|ABBV261.89+4.77 (+1.86%) ▲|ABT103.10+1.15 (+1.13%) ▲|ACN190.40+6.50 (+3.53%) ▲|ADBE262.85+10.62 (+4.21%) ▲|AMAT431.29-25.20 (-5.52%) ▼|AMD491.32-24.81 (-4.81%) ▼|AMGN379.28+1.93 (+0.51%) ▲|AMT177.33-0.52 (-0.29%) ▼|AMZN253.97-2.81 (-1.09%) ▼|AVGO347.41-14.58 (-4.03%) ▼|AXP325.23+0.54 (+0.16%) ▲|BA209.45-1.00 (-0.48%) ▼|BAC61.70-1.00 (-1.59%) ▼|BKNG175.91+1.99 (+1.14%) ▲|BLK1,066.20-13.46 (-1.25%) ▼|BMY64.19+0.55 (+0.86%) ▲|BNY159.54-3.12 (-1.92%) ▼|BRK-B513.71+3.34 (+0.65%) ▲|C134.54-4.28 (-3.08%) ▼|CAT786.89-31.68 (-3.87%) ▼|CL88.32+1.52 (+1.75%) ▲|CMCSA25.08-0.13 (-0.50%) ▼|COF205.93-2.37 (-1.14%) ▼|COP138.16+0.81 (+0.59%) ▲|COST916.02+11.25 (+1.24%) ▲|CRM256.53+8.81 (+3.56%) ▲|CSCO110.96-1.17 (-1.04%) ▼|CVS95.35+0.69 (+0.72%) ▲|CVX214.42+0.36 (+0.17%) ▲|DE687.34+11.60 (+1.72%) ▲|DHR199.93-0.21 (-0.10%) ▼|DIS108.66+2.11 (+1.98%) ▲|DUK118.78-0.64 (-0.54%) ▼|EMR147.94-4.26 (-2.80%) ▼|FDX312.60+1.83 (+0.59%) ▲|GD357.05+1.15 (+0.32%) ▲|GE317.11-6.55 (-2.02%) ▼|GEV876.00-81.27 (-8.49%) ▼|GILD145.53+1.81 (+1.26%) ▲|GM86.22+0.60 (+0.70%) ▲|GOOG342.05+6.60 (+1.97%) ▲|GOOGL345.39+6.89 (+2.03%) ▲|GS1,000.43-28.75 (-2.79%) ▼|HD309.87+1.13 (+0.36%) ▲|HON199.26-3.11 (-1.53%) ▼|IBM247.76+4.47 (+1.84%) ▲|INTC97.90-5.04 (-4.90%) ▼|INTU338.12+16.55 (+5.15%) ▲|ISRG374.04+4.89 (+1.32%) ▲|JNJ268.52+2.94 (+1.11%) ▲|JPM350.88-5.35 (-1.50%) ▼|KO88.91+0.62 (+0.70%) ▲|LIN462.96-3.27 (-0.70%) ▼|LLY1,146.89+31.19 (+2.80%) ▲|LMT529.15+4.96 (+0.95%) ▲|LOW197.92+1.10 (+0.56%) ▲|LRCX277.89-20.33 (-6.82%) ▼|MA575.11+5.92 (+1.04%) ▲|MCD257.99+5.46 (+2.16%) ▲|MDLZ62.29-0.15 (-0.24%) ▼|MDT93.12+2.16 (+2.37%) ▲|META659.63+11.60 (+1.79%) ▲|MMM160.99-3.98 (-2.41%) ▼|MO70.54+1.56 (+2.25%) ▲|MRK144.78+0.85 (+0.59%) ▲|MS209.52-4.87 (-2.27%) ▼|MSFT505.28+9.65 (+1.95%) ▲|MU924.41-50.85 (-5.21%) ▼|NEE81.85-0.47 (-0.56%) ▼|NFLX80.37+2.97 (+3.84%) ▲|NKE37.22+0.42 (+1.13%) ▲|NOW141.65+9.12 (+6.88%) ▲|NVDA211.93-6.36 (-2.91%) ▼|ORCL144.70-5.59 (-3.72%) ▼|PEP136.24-0.08 (-0.06%) ▼|PFE27.77+0.05 (+0.19%) ▲|PG146.06+0.79 (+0.54%) ▲|PLTR171.55+4.32 (+2.58%) ▲|PM193.36+2.30 (+1.20%) ▲|QCOM178.71-3.26 (-1.79%) ▼|RTX195.24-2.44 (-1.23%) ▼|SBUX98.44-0.30 (-0.30%) ▼|SCHW107.43+0.18 (+0.17%) ▲|SO86.82-0.35 (-0.40%) ▼|SPG206.10+1.27 (+0.62%) ▲|T26.28+0.22 (+0.84%) ▲|TMO607.77-2.05 (-0.34%) ▼|TMUS183.13+0.80 (+0.44%) ▲|TSLA363.34-2.10 (-0.57%) ▼|TXN263.67-5.03 (-1.87%) ▼|UBER72.27+0.60 (+0.84%) ▲|UNH384.35+7.58 (+2.01%) ▲|UNP283.89-0.52 (-0.18%) ▼|UPS101.70+1.42 (+1.42%) ▲|USB62.82-0.02 (-0.03%) ▼|V376.00+5.55 (+1.50%) ▲|VZ51.13+0.52 (+1.02%) ▲|WFC88.54-1.75 (-1.94%) ▼|WMT109.06+1.91 (+1.78%) ▲|XOM165.91-0.09 (-0.05%) ▼|AAPL332.77+0.50 (+0.15%) ▲|ABBV261.89+4.77 (+1.86%) ▲|ABT103.10+1.15 (+1.13%) ▲|ACN190.40+6.50 (+3.53%) ▲|ADBE262.85+10.62 (+4.21%) ▲|AMAT431.29-25.20 (-5.52%) ▼|AMD491.32-24.81 (-4.81%) ▼|AMGN379.28+1.93 (+0.51%) ▲|AMT177.33-0.52 (-0.29%) ▼|AMZN253.97-2.81 (-1.09%) ▼|AVGO347.41-14.58 (-4.03%) ▼|AXP325.23+0.54 (+0.16%) ▲|BA209.45-1.00 (-0.48%) ▼|BAC61.70-1.00 (-1.59%) ▼|BKNG175.91+1.99 (+1.14%) ▲|BLK1,066.20-13.46 (-1.25%) ▼|BMY64.19+0.55 (+0.86%) ▲|BNY159.54-3.12 (-1.92%) ▼|BRK-B513.71+3.34 (+0.65%) ▲|C134.54-4.28 (-3.08%) ▼|CAT786.89-31.68 (-3.87%) ▼|CL88.32+1.52 (+1.75%) ▲|CMCSA25.08-0.13 (-0.50%) ▼|COF205.93-2.37 (-1.14%) ▼|COP138.16+0.81 (+0.59%) ▲|COST916.02+11.25 (+1.24%) ▲|CRM256.53+8.81 (+3.56%) ▲|CSCO110.96-1.17 (-1.04%) ▼|CVS95.35+0.69 (+0.72%) ▲|CVX214.42+0.36 (+0.17%) ▲|DE687.34+11.60 (+1.72%) ▲|DHR199.93-0.21 (-0.10%) ▼|DIS108.66+2.11 (+1.98%) ▲|DUK118.78-0.64 (-0.54%) ▼|EMR147.94-4.26 (-2.80%) ▼|FDX312.60+1.83 (+0.59%) ▲|GD357.05+1.15 (+0.32%) ▲|GE317.11-6.55 (-2.02%) ▼|GEV876.00-81.27 (-8.49%) ▼|GILD145.53+1.81 (+1.26%) ▲|GM86.22+0.60 (+0.70%) ▲|GOOG342.05+6.60 (+1.97%) ▲|GOOGL345.39+6.89 (+2.03%) ▲|GS1,000.43-28.75 (-2.79%) ▼|HD309.87+1.13 (+0.36%) ▲|HON199.26-3.11 (-1.53%) ▼|IBM247.76+4.47 (+1.84%) ▲|INTC97.90-5.04 (-4.90%) ▼|INTU338.12+16.55 (+5.15%) ▲|ISRG374.04+4.89 (+1.32%) ▲|JNJ268.52+2.94 (+1.11%) ▲|JPM350.88-5.35 (-1.50%) ▼|KO88.91+0.62 (+0.70%) ▲|LIN462.96-3.27 (-0.70%) ▼|LLY1,146.89+31.19 (+2.80%) ▲|LMT529.15+4.96 (+0.95%) ▲|LOW197.92+1.10 (+0.56%) ▲|LRCX277.89-20.33 (-6.82%) ▼|MA575.11+5.92 (+1.04%) ▲|MCD257.99+5.46 (+2.16%) ▲|MDLZ62.29-0.15 (-0.24%) ▼|MDT93.12+2.16 (+2.37%) ▲|META659.63+11.60 (+1.79%) ▲|MMM160.99-3.98 (-2.41%) ▼|MO70.54+1.56 (+2.25%) ▲|MRK144.78+0.85 (+0.59%) ▲|MS209.52-4.87 (-2.27%) ▼|MSFT505.28+9.65 (+1.95%) ▲|MU924.41-50.85 (-5.21%) ▼|NEE81.85-0.47 (-0.56%) ▼|NFLX80.37+2.97 (+3.84%) ▲|NKE37.22+0.42 (+1.13%) ▲|NOW141.65+9.12 (+6.88%) ▲|NVDA211.93-6.36 (-2.91%) ▼|ORCL144.70-5.59 (-3.72%) ▼|PEP136.24-0.08 (-0.06%) ▼|PFE27.77+0.05 (+0.19%) ▲|PG146.06+0.79 (+0.54%) ▲|PLTR171.55+4.32 (+2.58%) ▲|PM193.36+2.30 (+1.20%) ▲|QCOM178.71-3.26 (-1.79%) ▼|RTX195.24-2.44 (-1.23%) ▼|SBUX98.44-0.30 (-0.30%) ▼|SCHW107.43+0.18 (+0.17%) ▲|SO86.82-0.35 (-0.40%) ▼|SPG206.10+1.27 (+0.62%) ▲|T26.28+0.22 (+0.84%) ▲|TMO607.77-2.05 (-0.34%) ▼|TMUS183.13+0.80 (+0.44%) ▲|TSLA363.34-2.10 (-0.57%) ▼|TXN263.67-5.03 (-1.87%) ▼|UBER72.27+0.60 (+0.84%) ▲|UNH384.35+7.58 (+2.01%) ▲|UNP283.89-0.52 (-0.18%) ▼|UPS101.70+1.42 (+1.42%) ▲|USB62.82-0.02 (-0.03%) ▼|V376.00+5.55 (+1.50%) ▲|VZ51.13+0.52 (+1.02%) ▲|WFC88.54-1.75 (-1.94%) ▼|WMT109.06+1.91 (+1.78%) ▲|XOM165.91-0.09 (-0.05%) ▼|
22.2 C
New York
Monday, September 14, 2026

Tag: analysis

newssourceFORcompanyinformationcontent1releasesmarket

ADT Announces Launch of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

ADT Inc. (NYSE: ADT) today announced a proposed secondary public offering of 71,000,000 shares of the Company’s common stock.

Universal Logistics Holdings, Inc. Reports Second Quarter 2025 Financial Results; Declares Dividend

Second Quarter 2025 Operating Revenues: $393.8 million, down 14.8%Second Quarter 2025 Operating Income: $19.9 million, down $27.2 millionSecond Quarter 2025 Earnings Per Share: $0.32...

Circle K Crowns Rock, Paper, Prizes the Official Game of Summer 2025

Your favourite childhood game, just got an upgrade with three chances to win $25K cash, Sunwing travel and over two million instant prizes LAVAL, QC,...

[Latest] Global CRISPR Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report,...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global CRISPR Gene Editing Market size & share revenue was valued at approximately USD 3.65 Billion in 2024 and is expected to reach USD 4.10 Billion in 2025 and is expected to reach around USD 12.6 Billion by 2034, at a CAGR of 13.01% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are CRISPR Therapeutics AG, Agilent Technologies Inc., Thermo Fisher Scientific Inc., GeneCopoeia Inc., Synthego Corporation, System Biosciences LLC, ToolGen Inc., Rockland Immunochemicals Inc., Horizon Discovery Group PLC, Abcam Inc., Applied StemCell Inc., Cellecta Inc and others. 
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global CRISPR Gene Editing Market size & share revenue was valued at approximately USD 3.65 Billion in 2024 and is expected to reach USD 4.10 Billion in 2025 and is expected to reach around USD 12.6 Billion by 2034, at a CAGR of 13.01% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are CRISPR Therapeutics AG, Agilent Technologies Inc., Thermo Fisher Scientific Inc., GeneCopoeia Inc., Synthego Corporation, System Biosciences LLC, ToolGen Inc., Rockland Immunochemicals Inc., Horizon Discovery Group PLC, Abcam Inc., Applied StemCell Inc., Cellecta Inc and others.

SouthState Corporation Reports Second Quarter 2025 Results, Declares an Increase in the Quarterly Cash Dividend

WINTER HAVEN, Fla., July 24, 2025 /PRNewswire/ -- SouthState Corporation ("SouthState" or the "Company") (NYSE: SSB) today released its unaudited results of operations and...

Merakris Therapeutics Spotlights Investigational New Drug, MTX-001, with Innovation Showcase Win at 2025 Advanced Wound Care Summit

MTX-001 recognized for its clinical and commercial potential for treating chronic non-healing venous leg ulcers (VLUs) 
MTX-001 recognized for its clinical and commercial potential for treating chronic non-healing venous leg ulcers (VLUs)

Cabometyx® approved in the EU for previously treated advanced neuroendocrine tumors

PARIS, FRANCE, 24 July 2025 - Ipsen announced today that the European Commission has approved Cabometyx® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated pancreatic (pNET) and extra-pancreatic (epNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues.

Americase to Speak on Battery Regulations at 2025 OCP APAC Summit

Panel to explore regulatory challenges and alternatives to lithium-ion batteries in next-generation data centers WAXAHACHIE, Texas, July 24, 2025 /PRNewswire/ -- Americase, a leading manufacturer of...

Automotive IDM Market Size to Grow USD 14450 Million by 2031 at a CAGR of 11.9% | Valuates Reports

BANGALORE, India, July 24, 2025 /PRNewswire/ -- Automotive IDM Market is Segmented by Type (Advanced Packaging, Mainstream Packaging), by Application (Leadframe, MEMS & Sensors,...

Nexity – First-Half 2025 Results – Press release

FIRST-HALF 2025 RESULTS

Omniscient and The Jacobs Institute, Inc. Announce Strategic Partnership to Pioneer Clinical Connectomics

Omniscient and The Jacobs Institute launch Connectomics Innovation Program to advance stroke recovery and neurologic care with AI-enabled software.

Europe Pyridine Industry Analysis Report 2025-2033 | Germany and France Lead with Strong Agricultural and Pharmaceutical Sectors, Green Chemistry Drive Usage in the UK...

The Europe Pyridine Market is set to grow from USD 198.85 million in 2024 to USD 288.21 million by 2033, at a CAGR of 4.21%. This growth is driven by rising demand in agrochemicals, pharmaceuticals, and food industries. Pyridine's versatility in solvents, pesticides, and chemical intermediates bolsters its usage in Europe. Key market drivers include sustainable agriculture and pharmaceutical expansion, particularly in France and Germany. However, challenges like stringent environmental regulations and volatile raw material prices persist. Leading players like Lonza Group and Bayer AG are pivotal in shaping the market. 
The Europe Pyridine Market is set to grow from USD 198.85 million in 2024 to USD 288.21 million by 2033, at a CAGR of 4.21%. This growth is driven by rising demand in agrochemicals, pharmaceuticals, and food industries. Pyridine's versatility in solvents, pesticides, and chemical intermediates bolsters its usage in Europe. Key market drivers include sustainable agriculture and pharmaceutical expansion, particularly in France and Germany. However, challenges like stringent environmental regulations and volatile raw material prices persist. Leading players like Lonza Group and Bayer AG are pivotal in shaping the market.

Cascadia Announces Fully Subscribed C$3M Non-Brokered Private Placement

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, July 24, 2025 /CNW/ - Cascadia Minerals Ltd. ("Cascadia")...

Structured Data Management Software Business Analysis Report 2025 | Market to Reach $99 Billion by 2030 – Explosion of Enterprise Data Volumes Spurs Demand,...

Key market opportunities in the Structured Data Management Software sector include the rise of cloud deployments, with a strong CAGR, and significant growth in China. Enterprises prioritize structured solutions for data-driven decisions and compliance, while hybrid-cloud setups and AI-readiness drive market expansion. 
Key market opportunities in the Structured Data Management Software sector include the rise of cloud deployments, with a strong CAGR, and significant growth in China. Enterprises prioritize structured solutions for data-driven decisions and compliance, while hybrid-cloud setups and AI-readiness drive market expansion.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAnalysis

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers